SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-091819
Filing Date
2024-10-29
Accepted
2024-10-29 17:21:30
Documents
16
Period of Report
2024-10-23
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0219071-8k_avalon.htm   iXBRL 8-K 26173
2 CERTIFICATE OF AMENDMENT DATED OCTOBER 23, 2024 ea021907101ex3-1_avalon.htm EX-3.1 1200
3 GRAPHIC ex3-1_001.jpg GRAPHIC 445486
4 GRAPHIC ex3-1_002.jpg GRAPHIC 399474
  Complete submission text file 0001213900-24-091819.txt   1367661

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE albt-20241023.xsd EX-101.SCH 3039
6 XBRL LABEL FILE albt-20241023_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE albt-20241023_pre.xml EX-101.PRE 22375
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0219071-8k_avalon_htm.xml XML 3803
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38728 | Film No.: 241406743
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)